Print page Print page  Add to favourites  E-mail this site   

Management & platform partners

 
International competition accelerates the need for improved and cost-effective production and process facilities.

The establishment of world-class research that enables the development of radically new methods of optimising the processes used by biotech businesses is a precondition for satisfying this need.

BIOPRO’s activities are based on the challenges facing everyday industrial production. The businesses involved are global players in their respective industries. No matter if the end products are industrial enzymes, pharmaceuticals, bio-based energy or food ingredients, the ability to understand and manage production processes is a key parameter with great significance to the ability to compete in the world market.
 



Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology.
CP Kelco
www.cpkelco.com
From the world's largest pectin production plant, located in Lille Skensved, CP Kelco supplies a major share of the pectin and carrageenan used in global food production. Pectin is extracted from citrus peel, while carrageenan is made on the basis of seaweed. The end products are used to provide food, pharmaceuticals etc. the desired texture.



Novo Nordisk
www.novonordisk.com
Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,900 employees in 75 countries, and markets its products in more than 190 countries. The factories in Kalundborg represent the largest production area in Novo Nordisk, and a substantial amount of the world’s insulin is produced at the site.
Novozymes
www.novozymes.com
Novozymes is a world leader in bioinnovation. Together with customers in a number of industries we create tomorrow's industrial biological solutions to improve our customers' business and the exploitation of the world's resources. With more than 700 products in 130 countries, Novozymes' bioinnovations improve the results of the industry while at the same time securing the world's resources thanks to superior, sustainable solutions to tomorrow's market needs. Novozymes has production facilities several places in the world and the plant in Kalundborg handles the largest and most advanced enzyme production in the world.

 
Meet BIOPRO at High Tech Summit 2018

25 of the world's greatest biotech talents zoom in on the biotech industry in Region Zealand

BIOPRO strengthens Danish biotech

Projekt-entrepreneur/kreativ ingeniør til udvikling af nye virksomheder og med potentiale som CTO/CEO i en spin-out

Inspirational BIOPRO World Talent Campus

BIOPRO World Talent Campus challenges international PhD students

BIOPRO World Talent Campus in Danish media

Fremtidens videnskabsfolk føres sammen på Sjælland

Biotech talents from all over the world meet at BIOPRO World Talent Campus
BIOPRO poster at the CAPEC-PROCESS 2015 meeting
At the Annual DTU CAPEC-PROCESS meeting a BIOPRO project poster was presented. The CAPEC-PROCESS annual meeting was held in Copenhagen on June 5, 2015.
Invitation to BIOPRO World Talent Campus

From the 18th to the 22nd of August the World Talent Campus gathers 24 of the world's leading talents within biotech production. The invitation to the closing presentation at the event has been sent out now.

University talents learned about the opportunities offered by BIOPRO Academy

University students and high-school talents recently gathered at BIOPRO Academy in Kalundborg, Denmark, to hear more about BIOPRO and the projects supported by the partnership. 

BIOPRO boosts growth for small enterprise

The small enterprise Q-Interline has worked out a new business concept on the back of the results achieved by the BIOPRO partnership. 

Based on its collaboration with BIOPRO, Q-Interline has developed its production and now expects its turnover in the after-sales market to soar by 50 percent.

How to get more innovation out of R&D billions

In spite of a high level of R&D Denmark does not get enough innovation out of its investments. BIOPRO has developed a new collaboration model to strengthen ties between universities and industry. The aim is more growth and job creation.


Arrangementer
  
 

Copyright © BIOPRO - All Rights Reserved.

CMS - Content Management System by Media2.